(1s,4s)-4-(6-amino-2-chloro-9H-purin-9-yl)-N-(1H-imidazol-2-yl)cyclohexanecarboxamide

ID: ALA5094555

PubChem CID: 134214642

Max Phase: Preclinical

Molecular Formula: C15H17ClN8O

Molecular Weight: 360.81

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1nc(Cl)nc2c1ncn2[C@H]1CC[C@@H](C(=O)Nc2ncc[nH]2)CC1

Standard InChI:  InChI=1S/C15H17ClN8O/c16-14-21-11(17)10-12(22-14)24(7-20-10)9-3-1-8(2-4-9)13(25)23-15-18-5-6-19-15/h5-9H,1-4H2,(H2,17,21,22)(H2,18,19,23,25)/t8-,9+

Standard InChI Key:  QKUXDTKTFLFIJR-DTORHVGOSA-N

Molfile:  

 
     RDKit          2D

 25 28  0  0  0  0  0  0  0  0999 V2000
   27.5283  -21.9595    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.2380  -21.5501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.2352  -20.7274    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.5266  -20.3222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8203  -21.5506    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8215  -20.7340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0453  -20.4805    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.5643  -21.1404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0434  -21.8017    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.5228  -19.5050    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.7897  -22.5785    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9909  -22.7420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7365  -23.5148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2794  -24.1260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0804  -23.9590    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.3383  -23.1808    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0228  -24.9018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.2226  -25.0675    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.6790  -24.4574    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.5664  -25.5120    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.9464  -21.9576    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   23.8500  -23.6549    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.1445  -23.2426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5343  -23.7862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8628  -24.5344    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  5  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9  5  1  0
  4 10  1  0
 11  9  1  1
 11 12  1  0
 11 16  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 14 17  1  1
 17 18  1  0
 18 19  1  0
 17 20  2  0
  2 21  1  0
 19 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 19  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5094555

    ---

Associated Targets(Human)

CHKA Tchem Choline kinase alpha (330 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHKB Tbio Choline/ethanolamine kinase (45 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 360.81Molecular Weight (Monoisotopic): 360.1214AlogP: 2.15#Rotatable Bonds: 3
Polar Surface Area: 127.40Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 8.95CX Basic pKa: 3.70CX LogP: 1.62CX LogD: 1.61
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.61Np Likeness Score: -0.98

References

1. Quartieri F, Nesi M, Avanzi NR, Borghi D, Casale E, Corti E, Cucchi U, Donati D, Fasolini M, Felder ER, Galvani A, Giorgini ML, Lomolino A, Menichincheri M, Orrenius C, Perrera C, Re Depaolini S, Riccardi-Sirtori F, Salsi E, Isacchi A, Gnocchi P..  (2021)  Identification of unprecedented ATP-competitive choline kinase inhibitors.,  51  [PMID:34416377] [10.1016/j.bmcl.2021.128310]

Source